GSK declares a big win with positive topline results for its adult RSV vaccine. But the jury's still out on bottom line efficacy

Emma Walmsley’s bet on making GSK a pure play Big Pharma innovator just cleared a major milestone. But the GSK team is not home free …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

GSK de­clares a big win with pos­i­tive topline re­sults for its adult RSV vac­cine. But the ju­ry's still out on bot­tom line ef­fi­ca­cy